CSPC Pharmaceutical’s Valsartan and Levamlodipine Maleate Tablets (SYH9056) Accepted by NMPA for Hypertension Treatment 1
CSPC Pharmaceutical Group: NMPA Acceptance of New Hypertensi...
Sign in to continue:
CSPC Pharmaceutical Group: NMPA Acceptance of New Hypertensi...
Mei Ah Entertainment Group Limited Announces Board Meeting t...
Minieye Technology Signs Major Driverless Logistics Vehicle ...
LVGEM (China) Real Estate Investment Company Limited Announc...
China Suntien Green Energy: Shareholding Increase by Control...
Sino Harbour Holdings Group Announces Board Meeting for FY20...
Thelloy Development Group Profit Warning - Reduction in Loss...
Elife Holdings Limited Announces Upcoming Board Meeting to A...
Tongguan Gold Group Announces Up to HK\$300 Million Share Re...
Modern Innovative Digital Technology Company Limited Announc...